- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03299153
The Effects of Barberry Juice Consumption in Patients With Type 2 Diabetes
September 29, 2017 updated by: Dr Azita Hekmatdoost, National Nutrition and Food Technology Institute
The Effects of Barberry Juice Consumption on Glycaemic Control, Lipid Profile, Blood Pressure and Oxidative Stress in Patients With Type 2 Diabetes: A Randomized Clinical Trial
The aim of this study was to investigate the effect of barberry juice (BJ) as a natural antioxidant, on cardiovascular risk factors in patients with type 2 diabetes (T2DM).
In a randomized clinical trial study, 46 T2DM patients, 30-70 years old recruited from "Diabetes Association of Iran-Babul ".
Patients were randomly allocated to either the BJ group (n=23) who consumed 200 ml of BJ daily for eight weeks, or the control group (n=23) with no intervention.
At the baseline and the end of 8-week intervention, blood pressure and biochemical markers were conducted.
Study Overview
Study Type
Interventional
Enrollment (Actual)
46
Phase
- Phase 4
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Fasting blood glucose>100 mg/dL (5.6 mmol /L)
- Systolic blood pressure>130 mmHg or diastolic blood pressure>85mmHg
- Triglycerides> 150 mg/dL (1.7 mmol/L)
Exclusion Criteria:
- taking insulin
- smoking
- using antioxidant supplements
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention group
patients in this group were received 200 ml/d barberry juice for tow month
|
|
No Intervention: control group
patients in this group received no intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
fasting blood glucose
Time Frame: 8 weeks
|
8 weeks
|
total cholesterol
Time Frame: 8 weeks
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
HbA1c
Time Frame: 8 weeks
|
8 weeks
|
Triglyceride
Time Frame: 8 weeks
|
8 weeks
|
LDL- cholesterol
Time Frame: 8 weeks
|
8 weeks
|
HDL- cholesterol
Time Frame: 8 weeks
|
8 weeks
|
Systolic BP
Time Frame: 8 weeks
|
8 weeks
|
Diastolic BP
Time Frame: 8 weeks
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 21, 2016
Primary Completion (Actual)
April 16, 2017
Study Completion (Actual)
August 5, 2017
Study Registration Dates
First Submitted
September 27, 2017
First Submitted That Met QC Criteria
September 29, 2017
First Posted (Actual)
October 2, 2017
Study Record Updates
Last Update Posted (Actual)
October 2, 2017
Last Update Submitted That Met QC Criteria
September 29, 2017
Last Verified
September 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1534
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes
-
Antonio Di MauroCompletedType-2 DiabetesItaly
-
DiaMedica Therapeutics IncCompletedDiabetes Type 2Netherlands
-
RenJi HospitalUnknownType 2 Diabetes.China
-
University of Erlangen-Nürnberg Medical SchoolCompletedType 2-diabetesGermany
-
Chengdu Brilliant Pharmaceutical Co., Ltd.Not yet recruitingType 2 Diabetes Mellitus
-
Nanjing First Hospital, Nanjing Medical UniversityRecruitingType 2 Diabetes MellitusChina
-
Xiangya Hospital of Central South UniversityRecruitingType 2 Diabetes MellitusChina
-
University of Alabama at BirminghamCompletedType 2 Diabetes MellitusUnited States
-
Imperial College LondonAstraZeneca; Huma; North West London Collaboration of CCGs (NWL CCGs); Imperial...CompletedType 2 Diabetes MellitusUnited Kingdom
-
Universiti Sains MalaysiaCompleted
Clinical Trials on barberry juice
-
Shahid Beheshti UniversityCompletedBlood Pressure | Cardiovascular Risk Factor | Lipid ProfileIran, Islamic Republic of
-
Birjand University of Medical SciencesCompletedHyperglycemia | Metabolic Syndrome | Hypercholesterolemia | HypertriglyceridemiaIran, Islamic Republic of
-
San Diego State UniversityRecruiting
-
University of North Carolina, Chapel HillNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedFeeding Behavior | Inhibition (Psychology)
-
Universidad Francisco de VitoriaUniversity of Alcala; University of SevilleCompleted
-
University of Colorado, DenverCompletedProstate CancerUnited States
-
Karolinska InstitutetRecruiting
-
Northumbria UniversityCompletedCognitive Impairment | Cerebrovascular CirculationUnited Kingdom
-
Bangor UniversityCompleted